NDC 68788-7331

Tacrolimus

Tacrolimus

Tacrolimus is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Preferred Pharmaceuticals, Inc.. The primary component is Tacrolimus.

Product ID68788-7331_ea81bd40-ea82-45e3-9780-f4cbd0b301eb
NDC68788-7331
Product TypeHuman Prescription Drug
Proprietary NameTacrolimus
Generic NameTacrolimus
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2011-09-30
Marketing CategoryANDA / ANDA
Application NumberANDA091195
Labeler NamePreferred Pharmaceuticals, Inc.
Substance NameTACROLIMUS
Active Ingredient Strength1 mg/1
Pharm ClassesCalcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 68788-7331-6

60 CAPSULE in 1 BOTTLE (68788-7331-6)
Marketing Start Date2019-10-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68788-7331-3 [68788733103]

Tacrolimus CAPSULE
Marketing CategoryANDA
Application NumberANDA091195
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-10-25

NDC 68788-7331-1 [68788733101]

Tacrolimus CAPSULE
Marketing CategoryANDA
Application NumberANDA091195
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-10-25

NDC 68788-7331-6 [68788733106]

Tacrolimus CAPSULE
Marketing CategoryANDA
Application NumberANDA091195
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-10-25

NDC 68788-7331-9 [68788733109]

Tacrolimus CAPSULE
Marketing CategoryANDA
Application NumberANDA091195
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-10-25

Drug Details

Active Ingredients

IngredientStrength
TACROLIMUS1 mg/1

Pharmacological Class

  • Calcineurin Inhibitor Immunosuppressant [EPC]
  • Calcineurin Inhibitors [MoA]
  • Calcineurin Inhibitor Immunosuppressant [EPC]
  • Calcineurin Inhibitors [MoA]

NDC Crossover Matching brand name "Tacrolimus" or generic name "Tacrolimus"

NDCBrand NameGeneric Name
0093-3428Tacrolimustacrolimus
0093-3429Tacrolimustacrolimus
0168-0416Tacrolimustacrolimus
0168-0417Tacrolimustacrolimus
0378-2045TacrolimusTacrolimus
0378-2046TacrolimusTacrolimus
0378-2047TacrolimusTacrolimus
68084-450TacrolimusTacrolimus
68084-449TacrolimusTacrolimus
68084-451TacrolimusTacrolimus
68462-534TacrolimusTacrolimus
69452-154TacrolimusTacrolimus
69452-155TacrolimusTacrolimus
69452-153TacrolimusTacrolimus
70518-1168TacrolimusTacrolimus
0781-2104TacrolimusTacrolimus
0781-2102TacrolimusTacrolimus
0781-2103TacrolimusTacrolimus
0781-9302TacrolimusTacrolimus
0781-9304TacrolimusTacrolimus
0781-9303TacrolimusTacrolimus
0904-6425TacrolimusTacrolimus
0904-6624TacrolimusTacrolimus
0904-6623TacrolimusTacrolimus
16729-041TacrolimusTacrolimus
16729-043TacrolimusTacrolimus
16729-042TacrolimusTacrolimus
43353-317TacrolimusTacrolimus
43817-423TacrolimusTacrolimus
43817-422TacrolimusTacrolimus
43817-421TacrolimusTacrolimus
45802-390TacrolimusTacrolimus
45802-700TacrolimusTacrolimus
50090-2245TacrolimusTacrolimus
51079-817TacrolimusTacrolimus
51079-818TacrolimusTacrolimus
51079-028TacrolimusTacrolimus
55111-525TacrolimusTacrolimus
55111-526TacrolimusTacrolimus
55111-527TacrolimusTacrolimus
55154-5438TacrolimusTacrolimus
55154-4395TacrolimusTacrolimus
55154-2675TacrolimusTacrolimus
60429-378TacrolimusTacrolimus
60429-377TacrolimusTacrolimus
60429-379TacrolimusTacrolimus
62175-381TacrolimusTacrolimus
62250-665TacrolimusTacrolimus
62175-380TacrolimusTacrolimus
62175-382TacrolimusTacrolimus

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.